Synthèse documentaire ASEM
Document officiel de Canadian Paediatric Society (2023) sur « Medical cannabis for children: Evidence and recommendations ». Extrait officiel (langue source) : Interest in using cannabis products for a medical purpose in children under the age of 18 years is increasing. There are many medical cannabis products available that can include cannabidiol (CBD) or delta-9-tetrahydrocannabinol (THC), or both cannabinoids. Despite many therapeutic claims, there are few rigorous studies to inform the dosing, safety, and efficacy of medical cannabis used in paediatric clinical practic. Consultez la publication officielle pour les recommandations détaillées et leur champ d’application.
Cette synthèse facilite le repérage du document. Pour les recommandations cliniques, consultez toujours la version officielle et sa date de mise à jour.
Document officiel